← Leaderboards
Samuel Wall
Organos, Inc.
$3,465,880
Attributed
$3,465,880
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,465,880 · 2
By mechanism
R44$3,465,880 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationCardiacSoftware SystemsTissuesPredictive ToolsIn VitroDrug DiscoveryResponseIn SilicoSuccessPharmaceutical PreparationsMicrophysiology SystemDrug TestingPhysiologicalComputing MethodologiesComputer SoftwareDevicesLicensingHeartBeliefPre-Clinical ModelMedication SafetyDrug IndustryLead
Grant awards (5)
Microheart muscle based discovery and development of inotropic compounds$1,029,043
R44 · FY2025 · TR · contact PI
High-throughput Human Micro-Heart Muscle for Drug Discovery$351,332
R44 · FY2023 · TR · contact PI
High-throughput Human Micro-Heart Muscle for Drug Discovery$622,880
R44 · FY2022 · TR · contact PI
Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening$537,114
R44 · FY2021 · HL · contact PI
Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening$925,511
R44 · FY2020 · HL · contact PI